Expression of DNA damage response biomarkers during oral carcinogenesis

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 3, 2011, Pages 346-353

  Chou, Shan Ju ^a   Alawi, Faizan ^a  

^a Orthodontics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; H2AFX PROTEIN, HUMAN; HISTONE; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; THREONINE; TUMOR MARKER;

ARTICLE; BIOPSY; CELL TRANSFORMATION; DNA DAMAGE; DNA REPLICATION; EPITHELIUM; GENETICS; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH TUMOR; PATHOLOGY; PHOSPHORYLATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA DAMAGE; DNA REPLICATION; EPITHELIUM; GENES, TUMOR SUPPRESSOR; HISTONES; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; THREONINE; TUMOR MARKERS, BIOLOGICAL;

EID: 79951481127     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.10.032     Document Type: Article

References (21)

1. T.D. Halazonetis, V.G. Gorgoulis, and J. Bartek An oncogene-induced DNA damage model for cancer development Science 319 2008 1352 1355 (Pubitemid 351354863)
2. R.T. Abraham Cell cycle checkpoint signaling through the ATM and ATR kinases Genes Dev 15 2001 2177 2196 (Pubitemid 32843830)
3. S. Matsuoka, B.A. Ballif, A. Smogorzewska, E.R. McDonald, K.E. Hurov, and J. Luo ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage Science 316 2007 1160 1166 (Pubitemid 46877472)
4. A. Celeste, O. Fernandez-Capetillo, M.J. Kruhlak, D.R. Pilch, D.W. Staudt, and A. Lee Histone H2AX phosphorylation is dispensable for the initial recognition of DNA breaks Nat Cell Biol 5 2003 675 679 (Pubitemid 36818091)
5. S. Burma, B.P. Chen, M. Murphy, A. Kurimasa, and D.J. Chen ATM phosphorylates histone H2AX in response to DNA double-strand breaks J Biol Chem 276 2001 42462 42467
6. I.M. Ward, and J. Chen Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress J Biol Chem 276 2001 47759 47762
7. I.M. Ward, X. Wu, and J. Chen Threonine 68 of CHK2 is phosphorylated at sites of DNA strand breaks J Biol Chem 276 2001 47755 47758
8. Y. Chen, and R.Y. Poon The multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability Front Biosci 13 2008 5016 5029 (Pubitemid 351599655)
9. V.G. Gorgoulis, L.F. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, and T. Liloglou Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions Nature 434 2005 907 913 (Pubitemid 40559004)
10. J. Bartkova, Z. Horejsi, K. Koed, A. Krmer, F. Tort, and Z. Frederic DNA damage response as a candidate anticancer barrier in early human tumorigenesis Nature 434 2005 864 870 (Pubitemid 40558993)
11. K. Oka, T. Tanaka, T. Enoki, K. Yoshimura, M. Ohshima, and T. Murakami DNA damage signaling is activated during cancer progression in human colorectal carcinoma Cancer Biol Ther 9 2010 246 252
12. J.B. Koorstra, S.M. Hong, C. Shi, A.K. Meeker, J.K. Ryu, and G.J. Offerhaus Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia Mod Pathol 22 2009 1439 1445
13. G.P. Pfeifer, M.F. Denissenko, M. Olivier, N. Tretyakova, S.S. Hecht, and P. Hainaut Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 21 2002 7435 7451 (Pubitemid 35305599)
14. A.J. Yoon, J. Shen, H.C. Wu, C. Angelopoulos, S.R. Singer, and R. Chen Expression of activated checkpoint kinase 2 and histone 2AX in exfoliative oral cells after exposure to ionizing radiation Radiat Res 171 2009 771 775
15. A.J. Yoon, J. Shen, R.M. Santella, D.J. Zegarelli, R. Chen, and I.B. Weinstein Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma Cancer Epidemiol Biomarkers Prev 16 2007 2768 2772 (Pubitemid 351196335)
16. J. Bartkova, J. Falck, E. Raipertde Myets, N.E. Skakkebaek, J. Lukas, and J. Bartek Chk2 tumour suppressor protein in human spermatogenesis and testicular germ cell tumours Oncogene 20 2001 5897 5902 (Pubitemid 32937959)
17. J. Bartkova, P. Guldberg, K. Grønbaek, K. Koed, H. Primdahl, and K. Møller Aberrations of the CHK2 tumor suppressor in advanced urinary bladder cancer Oncogene 23 2004 8545 8551 (Pubitemid 39540805)
18. F. Tort, S. Hernndez, S. Be, A. Martnez, M. Esteller, and J.G. Herman CHK2-decreased protein expression and infrequent genetic alternations mainly occur in aggressive types of non-Hodgkin lymphoma Blood 100 2002 4602 4608 (Pubitemid 35429704)
19. V. Staalesen, J. Falck, S. Geisler, J. Bartkova, A.L. Børresen-Dale, and J. Lukas Alternative splicing and mutation status of CHK2 in stage III breast cancer Oncogene 23 2004 8535 8544 (Pubitemid 39540804)
20. M.P. Rethman, W. Carpenter, E.E. Cohen, J. Epstein, C.A. Evans, and C.M. Flaitz Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas J Am Dent Assoc 141 2010 509 520
21. C.A. Schmitt, J.S. Fridman, M. Yang, E. Baranov, R.M. Hoffman, and S.W. Lowe Dissecting p53 tumor suppressor function in vivo Cancer Cell 1 2002 289 298 (Pubitemid 41039153)